Viral Vectors
We develop and manufacture viral vectors that meet clinical and commercial demands for gene therapy products
Viral vector development and manufacturing expertise
AGC Biologics scientists have three decades of viral vector-based gene therapy expertise and specialize in adeno-associated viral vectors (AAV), lentiviral vectors (LVV), and retroviral vectors (RVV). Our sites in the U.S. and Italy have supported four commercial products.
Our ready-to-use platform capabilities for AAV and LVV programs are built on cell factories and bioreactors using adherent and suspension processes, designed entirely in-house.
Our quality systems, manufacturing scales, and regulatory expertise allow us to meet both clinical and commercial viral vector demands. Moreover, our scale-down capabilities provide flexible and cost-effective solutions for process development and pre-clinical studies.
Got a project? Let's talk.
A customized approach to viral vector production
Our research and lab work shows it is possible to build scalable off-the-shelf vector manufacturing processes able to accelerate the GMP process, reducing PD efforts, time and costs.
Like a tailor designs a suit, we can tailor your vector product to meet your project's exact specifications. This approach's flexibility also offers the possibility of replacing the GFP gene with any therapeutic genes through a simple cut-and-sew cloning strategy.
